Search clinical trials for: CHOP Rituximab

Total 3888 results

Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Completed

Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)

Lymphoma, B-Cell

Japan
Azienda Socio Sanitaria Territoriale degli Spedali...

Completed

High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk (HDT-HIV)

HIV Infections | HIV-related Lymphoma

Italy
Asan Medical Center

Unknown

Abbreviated R-CHOP in Completely Excised Stage I or II DLBCL

Diffuse Large B-cell Lymphoma

Korea, Republic of
Pusan National University Hospital

Unknown

Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and Over

Diffuse Large B-cell Lymphoma
Sinocelltech Ltd.

Unknown

A Study Comparing the Efficiency and Safety of S-CHOP(Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated CD20(Cluster of Differentiation Antigen 20)-Positive DLBCL Patients

Diffuse Large B Cell Lymphoma

China
University Hospital Southampton NHS Foundation...
Janssen-Cilag Ltd.

Completed

A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib (REMoDL-B)

Lymphoma, Large B-Cell, Diffuse

United Kingdom, Switzerland
Hoffmann-La Roche
Serbian Lymphoma Group

Completed

MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Non-Hodgkin's Lymphoma, Lymphoma, Non Hodgkin, Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Serbia
Wenqi Jiang

Unknown

R-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell Lymphoma

Lymphoma, Large B-Cell, Diffuse

China
Lymphoma Study Association
Amgen

Completed

R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma

Diffuse Large Cell Lymphoma

France, Belgium, Switzerland
Hospices Civils de Lyon

Completed

A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in Lymphoma (LNH2007-3B)

Lymphoma, B-Cell | Lymphoma, Large-Cell, Diffuse

France
Arbeitsgemeinschaft medikamentoese Tumortherapie

Completed

Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma (NHL-14)

Diffuse Large B-Cell Lymphoma

Austria
French Innovative Leukemia Organisation

Unknown

GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma

Lymphoma
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC

Completed

Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients

Lymphoma

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI); Southwest Oncology Group; Cancer and Leukemia...

Completed

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma

Lymphoma

United States
Nantes University Hospital

Completed

Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab

Lymphoma, Large-Cell, Diffuse

France
Washington University School of Medicine

Completed

Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma

Lymphoma | Diffuse Large Cell

United States
Australasian Leukaemia and Lymphoma Group
Merck Sharp & Dohme LLC

Unknown

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Lymphoma, Non-Hodgkin
Fudan University

Unknown

Interim PET/CT Guided Cycle Numbers of R-CHOP in DLBCL

Diffuse Large B-cell Lymphoma

China
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma

Lymphoma

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital; Millennium Pharmaceuticals, Inc.

Terminated

Ph II CHOP+Velcade in Mediastinal LBCL

Non-Hodgkin's Lymphoma

United States
Samsung Medical Center

Completed

Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL)

Diffuse Large B-cell Lymphoma (DLBCL)

Korea, Republic of
European Mantle Cell Lymphoma Network
Lymphoma Study Association; German Low Grade Lymphoma Study Group

Unknown

Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL

Lymphoma, Mantle-Cell

France, Germany, Poland
Swiss Group for Clinical Cancer Research

Completed

Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL

Leukemia

Switzerland
University of Giessen

Completed

Bendamustine Plus Rituximab Versus CHOP Plus Rituximab

Marginal Zone Lymphomas | Non-Hodgkin Lymphomas | Follicular Lymphomas | Immunocytomas | Lymphocytic Lymphomas

Germany
Fernando Cabanillas
Genzyme, a Sanofi Company

Completed

Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL (CHOP-R)

Lymphoma | Non Hodgkin's Lymphoma

Puerto Rico
CABYC
Bayer; Genzyme, a Sanofi Company; Fundacion Clinic per a la Recerca Biomedica; Grupo... and other collaborators

Withdrawn

R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic Leukemia (R-CHOP)

Chronic Lymphocytic Leukaemia | Patients Resistant to a Purine Analogous | Patients Relapsed With Purines Therapy

Spain
Fondazione Italiana Linfomi ONLUS

Completed

Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen (ProDLBCL)

B-Cell Lymphomas

Italy, Brazil
Charite University, Berlin, Germany

Terminated

Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)

Post-transplantation Lymphoproliferative Disorder

Australia, France, Germany, Sweden
Chonnam National University Hospital
Samsung Medical Center; Asan Medical Center; Severance Hospital

Unknown

Rituximab Augmentation Following R-CHOP Induction Chemotherapy in Extremely Elderly Patients With Diffuse Large B Cell Lymphoma

Lymphoma, Large B-cell, Diffuse

Korea, Republic of
Lymphoma Study Association
Amgen

Completed

ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1

Diffuse Large-Cell Lymphoma

France, Belgium
Fondazione Italiana Linfomi ONLUS

Unknown

Multicentric Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Patients With Stage II-IV Follicular Lymphoma

Follicular Lymphoma

Italy
SCRI Development Innovations, LLC
Biogen

Completed

Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's Lymphoma

Non-Hodgkins Lymphoma
Fondazione Italiana Linfomi ONLUS

Completed

R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL (ANZINTER3)

Diffuse Large B Cell Lymphoma (DLBCL) | Elderly Patients (>65 Years)

Italy
PETHEMA Foundation

Completed

LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV) (LINFOTARGAM)

HIV Infections | Diffuse Large B Cell Lymphoma

Spain
International Extranodal Lymphoma Study Group (IELSG)

Completed

Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma

Lymphoma, B Cell

Switzerland
University of Bologna

Completed

Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) in Elderly (More Than 60 Years) Patients With Diffuse Large B Cell Lymphoma After 4 Cycles of CHOP21-Rituximab (CHOP21-R) Therapy (CHOP21+R-Z)

Diffuse Large B-Cell Lymphoma

Italy
University Hospital Tuebingen
Hoffmann-La Roche

Completed

Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Primary Gastric Diffuse-Large B-Cell Lymphoma

Germany
Azienda Ospedaliera San Giovanni Battista
Hoffmann-La Roche; University of Turin, Italy; Gruppo Italiano Trapianto di Midollo... and other collaborators

Unknown

Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma

Follicular Lymphoma

Italy
Instituto Nacional de Cancerologia de Mexico

Unknown

Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

Non-Hodgkin Lymphoma

Mexico
French National Agency for Research on AIDS and...
Hoffmann-La Roche

Terminated

Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma

AIDS Related Lymphoma

France
The First Affiliated Hospital of Xiamen University
Fujian Cancer Hospital; Chinese PLA General Hospital; Jiangxi Provincial Cancer... and other collaborators

Recruiting

Prospective Clinical Study of Obrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Cell Lymphoma (MZL) That Failed or Not Suitable for Local Therapy

to Access the Effecicy and Safety of OR Therapy in Newly-diagnosed Marginal Zone Cell Lymphoma

China
Bartın Unıversity

Not yet recruiting

Changes in Dyspnea, Activity and Sleep in COPD by Video-Based Breathing Exercises

Pulmonary Disease, Chronic Obstructive

Turkey
Charite University, Berlin, Germany
Kyverna Therapeutics

Not yet recruiting

Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis (COMPARE)

Rheumatoid Arthritis
Dana-Farber Cancer Institute
Merck Sharp & Dohme LLC

Not yet recruiting

Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL

Lymphoma | Primary Central Nervous System Lymphoma

United States
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular Lymphoma

FL
Chinese PLA General Hospital

Recruiting

A Phase ll Trial of the Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma (ZARAV)

Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma

China
Hacettepe University

Recruiting

An Investigation of Different Type Single Limb Exercise Training Effects in Copd (COPD)

Exercise

Turkey
Koronis Biomedical Technologies
University of Chicago; National Institute on Aging (NIA)

Not yet recruiting

Inhaler Trainer Efficacy Study

Asthma | Copd | Acute Exacerbation of COPD
Elizabeth Austen Lawson

Not yet recruiting

Identifying Oxytocin Deficiency in Adults With Pituitary Disease

Oxytocin Deficiency | Arginine Vasopressin Deficiency
Institut Curie

Not yet recruiting

Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid (AVATAR)

Metastatic Breast Cancer

France

Search clinical trials for: CHOP Rituximab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations